(lp0
S'Can Illumina  Spring a Surprise this Earnings Season? Yahoo Finance - 20 hours ago In the last reported fourth quarter of 2016, Illumina continued to witness robust revenue growth on account of improvement in sequencing consumables and strong demand of microarrays.'
p1
aS"Here's Why the Best Is Yet to Come for Illumina, Inc. Motley Fool - Mar 21, 2017 A cursory glance at the stock chart for Illumina, Inc.  might make you think the good times are over for the genomic-sequencing leader.Next-Generation Sequencing Company Sets Sights on $100 Genome Analysis - OncLive"
p2
aS'Illumina to Announce First Quarter 2017 Financial Results on Tuesday, April 25 ... Business Wire  - Apr 3, 2017 SAN DIEGO----Illumina, Inc.  today announced that it will issue results for first quarter 2017 following the close of market on Tuesday, April 25, 2017.'
p3
aS'Kailos Genetics Announces Co-marketing Agreement with Illumina, Inc. for ... Business Wire  - Mar 21, 2017 BUSINESS WIRE)--Kailos Genetics, a personalized medicine company offering a leading-edge suite of tools for next-generation sequencing -based assays, today announced it has entered into a co-marketing agreement with Illumina, Inc. (NASDAQ:&nbsp;...'
p4
aS"Insider Trading Activity Illumina, Inc.   Director Sold 3000 ... Market Exclusive - Apr 14, 2017 A Blaine Bowman , Director of Illumina, Inc.  reportedly Sold 3,000 shares of the company's stock at an average price of 172.72 for a total transaction amount of $518,160.00 SEC Form."
p5
aS'Illumina, Inc.  Shares Sold by Regent Investment Management LLC Markets Daily - 11 hours ago Illumina logo Regent Investment Management LLC lowered its position in Illumina, Inc.  by 1.8% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission .Illumina, Inc.  Downgraded by Vetr Inc. - BBNSIllumina, Inc.  Given &quot;Overweight&quot; Rating at Piper Jaffray Companies - The Cerbat Gem'
p6
aS"Digging Up the Facts on Illumina, Inc.  StockNewsJournal - Mar 29, 2017 Illumina, Inc.  is an interesting player in the Healthcare space, with a focus on Biotechnology. The stock has been active on the tape, currently trading at $170.81, down from yesterday's close by -0.86%.Insider Trading Activity Illumina, Inc.   EVP Sold 1672 shares ... - Market ExclusiveInsider Selling: Illumina, Inc.  EVP Sells 1672 Shares of Stock - Community Financial News"
p7
aS'Analyst Consensus Recommendations on Illumina, Inc.  The Herald - Apr 14, 2017 Investors have the ability to follow analyst projections in order to help compile valuable company information. Out of the 16 covering Street analysts providing stock ratings for Illumina, Inc. , 9 have shares listed as a Strong Buy while ...'
p8
aS"Earnings Clues on Vornado Realty Trust , Illumina, Inc.  Analyst's ... StockNewsJournal - Mar 31, 2017 Illumina, Inc. , maintained return on investment for the last twelve months at 13.16, higher than what Reuters data shows regarding industry's average."
p9
aS'Trading Sheet: Watching the Levels for Illumina, Inc.  Searcy News - 20 hours ago Tracking shares of Illumina, Inc. , the company has a current EV  of 25612348. Enterprise Value measures the total value of a specific company.'
p10
a.